finally

Sarepta Therapeutics’ stock was soaring Tuesday after the FDA recommended lifting the pause on the company’s Duchenne…
Read More...

A for-sale sign hangs in front of a house in Patchogue, New York, on June 1, 2024.Steve Pfost | Newsday | Getty…
Read More...

A surge in trading of so-called “zero days to expiry” — or “0DTE” — options has taken financial markets by storm over…
Read More...